PSA kinetics and risk of death from prostate cancer: in search of the Holy Grail of surrogate end points

JAMA. 2005 Jul 27;294(4):493-4. doi: 10.1001/jama.294.4.493.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Humans
  • Male
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / mortality*
  • Risk Assessment

Substances

  • Prostate-Specific Antigen